ArticleScience advances2026
Continuous monitoring of blood-interstitial fluid intercompartmental molecular kinetics in freely moving animals.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combination of Polymeric Microneedles with Specific Peptide for TNF‑α Sensing Via Noninvasive Detection in Interstitial Fluid.ACS omega · 2026Article
- Charge-screening dominates signal transduction in electrochemical nucleic acid sensors for aminoglycosides.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Accurate health monitoring depends on continuous assessment of biochemical markers across multiple body compartments. While blood remains the clinical gold standard, interstitial fluid (ISF) presents a minimally invasive alternative that reflects local tissue physiology, although its biomarker kinetics often differ from blood. It is currently impossible to achieve simultaneous, continuous monitoring of both compartments, limiting insight into their dynamic relationship. To address this, we present BICEP (blood-ISF continuous-sensing electrochemical probe), a wireless electrochemical platform for continuous dual-compartment monitoring of analytes in blood and ISF. The BICEP system incorporates microfabricated soft sensors with biofouling-resistant aptamer interfaces, paired with a wearable potentiostat for remote configuration and readout. Using this system, we continuously tracked kanamycin signal in both anesthetized and freely moving rats, revealing distinct kinetic profiles and individualized temporal delays between blood and ISF signals. These findings confirm that ISF is not merely a proxy for blood but exhibits unique molecular kinetics influenced by individual variability and physiological state. This platform advances personalized health monitoring by providing integrated, dynamic correlation of blood and ISF biomarkers, deepening understanding of their physiological interplay under real-life conditions and paving the way for broader use of wearable ISF-based biosensors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.